Q1 EPS Estimates for HealthEquity Reduced by Zacks Research

HealthEquity, Inc. (NASDAQ:HQY - Free Report) - Investment analysts at Zacks Research decreased their Q1 2026 earnings per share (EPS) estimates for HealthEquity in a report released on Tuesday, April 8th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.63 for the quarter, down from their prior forecast of $0.68. The consensus estimate for HealthEquity's current full-year earnings is $2.32 per share. Zacks Research also issued estimates for HealthEquity's Q2 2026 earnings at $0.72 EPS, Q3 2026 earnings at $0.72 EPS, Q4 2026 earnings at $0.85 EPS, FY2026 earnings at $2.90 EPS, Q1 2027 earnings at $0.76 EPS, Q2 2027 earnings at $0.94 EPS, Q3 2027 earnings at $0.93 EPS, Q4 2027 earnings at $1.03 EPS and FY2027 earnings at $3.66 EPS.

Several other equities analysts have also recently commented on the company. The Goldman Sachs Group reduced their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. KeyCorp cut their price target on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Monday, March 24th. Wells Fargo & Company upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. Barrington Research reiterated an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a research report on Friday. Finally, Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $112.58.

Remove Ads

HealthEquity Price Performance

Shares of HQY stock traded down $0.33 during trading hours on Friday, reaching $83.03. The stock had a trading volume of 644,192 shares, compared to its average volume of 760,873. The stock's fifty day simple moving average is $97.05 and its 200 day simple moving average is $96.45. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $7.18 billion, a PE ratio of 76.17, a PEG ratio of 1.60 and a beta of 0.49. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59.

Insider Activity at HealthEquity

In other news, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at $4,433,820.30. This trade represents a 13.55 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 20,381 shares of company stock valued at $1,781,432. 2.20% of the stock is owned by insiders.

Hedge Funds Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently modified their holdings of HQY. EP Wealth Advisors LLC purchased a new position in HealthEquity in the third quarter worth about $340,000. Public Employees Retirement System of Ohio grew its position in HealthEquity by 5.6% during the third quarter. Public Employees Retirement System of Ohio now owns 91,754 shares of the company's stock valued at $7,510,000 after buying an additional 4,878 shares during the period. Barclays PLC increased its holdings in HealthEquity by 209.3% during the third quarter. Barclays PLC now owns 166,492 shares of the company's stock valued at $13,628,000 after buying an additional 112,667 shares during the last quarter. M&T Bank Corp raised its position in HealthEquity by 0.7% in the third quarter. M&T Bank Corp now owns 49,447 shares of the company's stock worth $4,047,000 after acquiring an additional 321 shares during the period. Finally, Geode Capital Management LLC boosted its stake in shares of HealthEquity by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company's stock worth $170,197,000 after acquiring an additional 15,145 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.